PCSK9 and acute coronary syndrome: Although lowering of LDL-C levels with PCSK9 inhibitors has been shown to reduce cardiovascular events in statin-treated patients with coronary artery disease and acute coronary syndrome,24 little information is available about other effects of long-term low LDL-C levels.